Symbols

CAH

Cardinal Health·NYSE

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 2

Consensus Rating "Buy"

High Cash/net Profit Ratio

EPS Below Expectations

Consecutive Gross Margin Decline

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CAH

Cardinal Health, Inc.

A distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities

Industry

Healthcare Providers and Services

Established Date

Listing Date

09/07/1994

Exchange

New York Stock Exchange

Full-time Employees

57,700

Fiscal Year Ends

06-30

Website

www.cardinalhealth.com

Security Type

Common stock

Office address

7000 Cardinal Place, Dublin, Ohio 43017

Business

Introduction

Cardinal Health, Inc., an Ohio company founded in 1979, is a globally integrated healthcare services and products company that provides customized solutions for hospitals, healthcare systems, pharmacies, outpatient surgery centers, clinical laboratories, physician offices and home patients. The company provides pharmaceutical and medical products and cost-effective solutions to improve supply chain efficiency. The company connects patients, providers, payers, pharmacists and manufacturers to achieve comprehensive care coordination and better patient management. The company manages its business and reports its financial results, divided into two parts: pharmaceutical and medical.

Company Financials

EPS

CAH has released its 2026 Q2 earnings. EPS was reported at 2.63, versus the expected 2.31, beating expectations. The chart below visualizes how CAH has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CAH has released its 2026 Q2 earnings report, with revenue of 65.63B, reflecting a YoY change of 18.75%, and net profit of 471.00M, showing a YoY change of 17.46%. The Sankey diagram below clearly presents CAH's revenue sources and cost distribution.